Press release
Chronic Heart Failure Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight
Chronic Heart Failure Market
[Nevada, United States] - DelveInsight's "Chronic Heart Failure Market Insights, Epidemiology, and Market Forecast 2032." report offers a detailed examination of Chronic Heart Failure, covering historical and predicted epidemiology, market trends, and treatment scenarios in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
To Know in detail about the Chronic Heart Failure Market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; https://www.delveinsight.com/report-store/chronic-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Key Findings from the Chronic Heart Failure Market Report:
The Chronic Heart Failure market size is poised for significant growth, with an anticipated Compound Annual Growth Rate (CAGR) during the study period (2019-2032).
In September, 2024: Tasly Pharmaceutical Group Co., Ltd announced that their main objective is to evaluate the efficacy, safety and clinical dose exploration of Qishen Yiqi dripping pills in the treatment of chronic heart failure with preserved ejection fraction
In August, 2024: AstraZeneca announced that the main purpose of their study is to evaluate the effect of AZD5462 on cardiac function in participants with chronic heart failure (HF).
In August, 2024: Novartis Pharmaceuticals announced that their study was a multi-center, randomized, double-blind, parallel group, active comparator trial designed to evaluate the overall effect of LCZ696 compared to valsartan on cognitive function as assessed by the CogState comprehensive cognitive battery in patients with Heart failure and preserved ejection fraction (HFpEF).
In August, 2024: Regeneron Pharmaceuticals announced that their study is being conducted to research an experimental drug called REGN5381 (called "study drug"). The study is focused on patients with heart failure with reduced ejection fraction (ie, the heart is not functioning as well as it should).
In August, 2024: Eli Lilly and Company announced that the main purpose of their study is to assess the efficacy and safety of LY3540378 in adults with worsening heart failure with preserved ejection fraction
Key Chronic Heart Failure Companies are as follows: AstraZeneca, Akros Pharma Inc., Zensun Sci. & Tech. Co., Ltd., Help Therapeutics, Regeneron Pharmaceuticals, Eli Lilly and Company, Cardurion Pharmaceuticals, Inc., Bayer
Key Chronic Heart Failure Therapies are as follow: Ertugliflozin, Metolazone, AZD5462, TSG-01, nesiritide, furosemide, JTT-861 Capsules, Levosimendan, rhNRG-1, RLX030 (serelaxin), pitavastatin, Irbesartan, Vasopressin V2 Receptor Antagonist, Bisoprolol, LCZ696, Valsartan, Cenderitide, elamipretide, conivaptan, Enalapril, Aliskiren and other...
Launching multiple stage Chronic Heart Failure pipeline products is expected to revolutionize market dynamics, further propelling market growth.
Dive into our detailed Chronic Heart Failure market research report to uncover actionable insights, industry forecasts, and competitive analysis @ https://www.delveinsight.com/sample-request/chronic-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Chronic Heart Failure Overview:
Chronic Heart Failure (CHF) is a condition where the heart's pumping ability is impaired, leading to symptoms like shortness of breath, fatigue, and swelling. It is often caused by underlying conditions like coronary artery disease or hypertension and requires lifelong management with medications, lifestyle changes, and sometimes surgical interventions to improve symptoms and outcomes. Early detection and comprehensive care are crucial for enhancing quality of life and reducing complications.
Chronic Heart Failure Drugs Uptake and Pipeline Development Activities:
The drugs uptake section focuses on the rate of uptake of potential drugs recently launched or expected to be launched during the study period. The report covers market uptake by drugs, patient uptake by therapies, and sales of each drug. Additionally, it provides insights into Chronic Heart Failure Pipeline Development Activities, analyzing therapeutic candidates in various stages and key companies involved.
For more information about Chronic Heart Failure companies working in the treatment market, visit: https://www.delveinsight.com/sample-request/chronic-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Chronic Heart Failure Therapies and Key Companies:
AZD5462: AstraZeneca
TSG-01: Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd.
nesiritide, furosemide: Scios, Inc.
JTT-861 Capsules: Akros Pharma Inc.
Levosimendan: Abbott
rhNRG-1: Zensun Sci. & Tech. Co., Ltd.
RLX030 (serelaxin): Novartis Pharmaceuticals
pitavastatin: JW Pharmaceutical
asopressin V2 Receptor Antagonist: Sanofi
valsartan 160 mg: Novartis
Bisoprolol: Merck KGaA, Darmstadt, Germany
Chronic Heart Failure Epidemiology:
The epidemiology section provides insights into historical, current, and forecasted trends in the seven major countries (7MM) from 2019 to 2032. It explores various studies and opinions to recognize the causes of current and forecasted trends. The segmentation includes total prevalence, severity-based prevalence, gender-specific prevalence, and diagnosed cases of episodic and chronic Chronic Heart Failure.
Seize Market Opportunities with Our Expert Analysis! Our report delivers valuable insights into market dynamics, key players, and emerging trends @ https://www.delveinsight.com/sample-request/chronic-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Chronic Heart Failure Epidemiology Segmentation:
The Chronic Heart Failure market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
Chronic Heart Failure Total Prevalence
Chronic Heart Failure Prevalent Cases by severity
Chronic Heart Failure Gender-specific Prevalence
Chronic Heart Failure Diagnosed Cases of Episodic and Chronic
Chronic Heart Failure Market Drivers:
Growing Prevalence of Heart Failure
Advances in Treatment Options
Increasing Healthcare Expenditure and Access to Treatment:
Research into Regenerative Medicine
Chronic Heart Failure Market Barriers:
High Cost of Advanced Treatments
Complex Disease Management
Side Effects and Drug Resistance
Lack of Awareness in Developing Regions
Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/chronic-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Scope of the Chronic Heart Failure Market Report:
Study Period: 2019-2032
Coverage: 7MM (The United States, EU5, and Japan)
Key Chronic Heart Failure Companies: AstraZeneca, Akros Pharma Inc., Zensun Sci. & Tech. Co., Ltd., Help Therapeutics, Regeneron Pharmaceuticals, Eli Lilly and Company, Cardurion Pharmaceuticals, Inc., Bayer
Key Chronic Heart Failure Therapies: Ertugliflozin, Metolazone, AZD5462, TSG-01, nesiritide, furosemide, JTT-861 Capsules, Levosimendan, rhNRG-1, RLX030 (serelaxin), pitavastatin, Irbesartan, Vasopressin V2 Receptor Antagonist, Bisoprolol, LCZ696, Valsartan, Cenderitide, elamipretide, conivaptan, Enalapril, Aliskiren and other...
Chronic Heart Failure Therapeutic Assessment: Current marketed and emerging therapies
Chronic Heart Failure Market Dynamics: Chronic Heart Failure Market drivers and Chronic Heart Failure barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Chronic Heart Failure Unmet Needs: Insights into unmet needs, KOL's views, Analyst's views, Market Access, and Reimbursement.
To access the full report and gain a deeper understanding of Chronic Heart Failure market outlook, drug uptake, treatment scenario, and epidemiology trends: https://www.delveinsight.com/sample-request/chronic-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Table of Content:
1. Key Insights
2. Executive Summary of Chronic Heart Failure
3. Competitive Intelligence Analysis for Chronic Heart Failure
4. Chronic Heart Failure: Market Overview at a Glance
5. Chronic Heart Failure: Disease Background and Overview
6. Patient Journey
7. Chronic Heart Failure Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Chronic Heart Failure Unmet Needs
10. Key Endpoints of Chronic Heart Failure Treatment
11. Chronic Heart Failure Marketed Products
12. Chronic Heart Failure Emerging Therapies
13. Chronic Heart Failure: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Chronic Heart Failure
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of TOP Selling Inhibitors Market Research Report as of 2024:
CTLA-4 Inhibitors Market: https://www.delveinsight.com/report-store/ctla4-inhibitors-market-forecast
VEGF Inhibitors Market: https://www.delveinsight.com/report-store/vegf-inhibitors-market-forecast
TROP-2 Inhibitors Market: https://www.delveinsight.com/report-store/trop2-inhibitors-market-forecast
HER2+ Market: https://www.delveinsight.com/report-store/her2-positive-market-forecast
HER3+ Market: https://www.delveinsight.com/report-store/her3-positive-market-forecast
FTase Inhibitors Market: https://www.delveinsight.com/report-store/ftase-inhibitors-market-forecast
Bispecifics Market: https://www.delveinsight.com/report-store/bispecifics-market-forecast
CAR-T Market: https://www.delveinsight.com/report-store/car-t-market-forecast
CD-19 Market: https://www.delveinsight.com/report-store/cd19-market-forecast
CD-20 Market: https://www.delveinsight.com/report-store/cd20-market-forecast
CD-38 Market: https://www.delveinsight.com/report-store/cd38-market-forecast
TP-53 Market: https://www.delveinsight.com/report-store/tp53-market-forecast
NTRK Market: https://www.delveinsight.com/report-store/ntrk-market-forecast
BRCA Market: https://www.delveinsight.com/report-store/brca-market-forecast
SMAD4/DPC4 Market: https://www.delveinsight.com/report-store/smad4-dpc4-market-forecast
Connective Tissue Growth Factor (CTGF) Inhibitors Market: https://www.delveinsight.com/report-store/connective-tissue-growth-factor-ctgf-inhibitors-market-forecast
Selective Inhibitor of the CXCR4 Chemokine Receptor Market: https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
PI3K Market: https://www.delveinsight.com/report-store/pi3k-market-forecast
FGFR Market: https://www.delveinsight.com/report-store/fgfr-market-forecast
PROTAC Market: https://www.delveinsight.com/report-store/protac-market-forecast
CEACAM5 Market: https://www.delveinsight.com/report-store/ceacam5-market-forecast
Anti Cancer Vaccine Market: https://www.delveinsight.com/report-store/anti-cancer-vaccine-market-forecast
Androgen Receptor Inhibitor Market: https://www.delveinsight.com/report-store/androgen-receptor-inhibitor-market-forecast
GnRH Receptor Antagonist Market: https://www.delveinsight.com/report-store/gnrh-receptor-antagonist-market-forecast
CDK4/6 Inhibitor Market: https://www.delveinsight.com/report-store/cdk4-6-inhibitor-market-forecast
SERD Market: https://www.delveinsight.com/report-store/serd-market-forecast
AKT Inhibitor Market: https://www.delveinsight.com/report-store/akt-inhibitor-market-forecast
Radioligand Therapies Market: https://www.delveinsight.com/report-store/radioligand-therapies-market-forecast
B7-H3 Market: https://www.delveinsight.com/report-store/b7-h3-market-forecast
CYP17 Inhibitor Market: https://www.delveinsight.com/report-store/cyp17-inhibitor-market-forecast
NTD AR Inhibitor Market: https://www.delveinsight.com/report-store/ntd-ar-inhibitor-market-forecast
NRG fusion Market: https://www.delveinsight.com/report-store/nrg-fusion-market-forecast
AXL Receptor Tyrosine Kinase Inhibitors Market: https://www.delveinsight.com/report-store/axl-receptor-tyrosine-kinase-inhibitors-market-forecast
PSMA-Targeted Therapy Market: https://www.delveinsight.com/report-store/psma-targeted-therapy-market-forecast
EGFR Market: https://www.delveinsight.com/report-store/egfr-market-forecast
ALK Market: https://www.delveinsight.com/report-store/alk-market-forecast
BRAF Market: https://www.delveinsight.com/report-store/braf-market-forecast
ERBB 2 Receptor Antagonists Market: https://www.delveinsight.com/report-store/erbb2-receptor-antagonists-market-forecast
VEGFR-2 Inhibitor Market: https://www.delveinsight.com/report-store/vegfr2-inhibitor-market-forecast
Thymidine Phosphorylase Inhibitors Market: https://www.delveinsight.com/report-store/thymidine-phosphorylase-inhibitors-market-forecast
DNA Synthesis Inhibitor Market: https://www.delveinsight.com/report-store/dna-synthesis-inhibitor-market-forecast
CD223 Antigen Inhibitors Market: https://www.delveinsight.com/report-store/cd223-antigen-inhibitors-market-forecast
BTK Inhibitors Market: https://www.delveinsight.com/report-store/btk-inhibitors-market-forecast
SERMS Market: https://www.delveinsight.com/report-store/serms-market-forecast
PLK1 Inhibitor Market: https://www.delveinsight.com/report-store/plk1-inhibitor-market-forecast
CD47 Antigen Inhibitors Market: https://www.delveinsight.com/report-store/cd47-antigen-inhibitors-market-forecast
RET Fusion Market: https://www.delveinsight.com/report-store/ret-fusion-market-forecast
ROS-1 Market: https://www.delveinsight.com/report-store/ros1-market-forecast
Mesenchymal-epithelial Transition Factor (MET) Market: https://www.delveinsight.com/report-store/mesenchymal-epithelial-transition-factor-met-market-forecast
MET Kinase Inhibitor Market: https://www.delveinsight.com/report-store/met-kinase-inhibitor-market-forecast
About DelveInsight:
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.
Contact Information:
Company Name: DelveInsight Business Research LLP
Contact Person: Ram Kapoor
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Heart Failure Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight here
News-ID: 3656916 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
